For functional studies of proteins, it is crucial to analyze individual domains systematically. This is usually performed by randomizing all amino acids of a domain or by varying a few conserved positions depending on the size and structural knowledge of the domain. The modified protein is then expressed in cellular systems to determine the effects caused by the changes in the sequence.
The classical protocol for domain randomization in the context of library production is usually performed using cloning techniques in bacteria. While the generally large number of independent clones obtained by this method is advantageous (1) , use of the library for applications in organisms other than bacteria requires extraction of plasmid DNA. This involves growth of the bacteria bearing the library, a process that can cause some loss of complexity due to uneven growth properties of individual clones.
For use in yeast, DNA sequence libraries have been produced directly in yeast by homologous recombination (2) . Library production in yeast is independent of in vitro ligation steps and passages through bacteria, because the process of homologous recombination is highly efficient resulting in 2 × 10 4 up to 3 × 10 6 clones per microgram vector DNA (3, 4) . The process requires production of a donor DNA bearing on each end 35-50 bp homology to the linearized target vector (5) . Fragments for use in homologous recombination can therefore be produced easily by PCR with primers bearing the homologous sequence at their 5′ ends. Even though the number of clones expected per microgram DNA is lower than in the classical cloning approach, library production in yeast for application in yeast combines the advantages of direct library analysis in this organism and easy experimental handling.
We have optimized the process of homologous recombination in yeast using replacement of the CDR3 of an antibody light chain variable domain as a model system. The primary structure of the coding sequence for a prototype single-chain antibody fragment (scFv) is depicted in Figure 1A . An scFv consists of the variable regions of the light (V L ) and heavy (V H ) chains connected to each other by a flexible linker. The affinity of identified scFvs can be improved by randomizing a few amino acids in one or several of the hypervariable sequences called CDR and by selecting for higher affinity antibodies (6) . The relatively low complexity of such CDR libraries and the prospect of producing and screening the library in one step in yeast prompted us to randomize the CDR3 V L by using homologous recombination. In the traditional approach for domain replacement using homologous recombination, shown in Figure 1A , the DNA sequence encoding the CDR3 V L of a prototype scFv would be removed with restriction enzymes to produce the target vector. Upon recombination, a donor DNA fragment providing homologies for recombination and also spanning the full CDR3 V L sequence lacking in the target DNA would integrate into the corresponding site of the target vector, thus allowing propagation in yeast. However, in a subset of clones, proper recombination with the donor DNA would not occur, thus generating background clones. Since the background clones of CDR libraries include binders, they will interfere with the selection assay for improved scFvs. We therefore considered including a negative selection marker for counter-selecting background clones. The negative selection marker replaces the CDR3 V L on the target vector and would be looped BENCHMARKS out upon correct homologous recombination ( Figure 1B ). In the case of vector background or nonhomologous recombination, expression of the negative marker would result in cell death ( Figure 1B) .
The Kluyveromyces lactis killer toxin γ-subunit (γ-toxin) was identified as a suitable negative selection marker for application in homologous recombination methods. It has been shown that simple intracellular expression of the γ-toxin lacking the signal peptide (referred to as KLGT) leads to irreversible G1 arrest in sensitive yeast cells (7, 8) . In contrast to the classical negative selection marker genes CYH2 and URA3 (9,10), counter-selection of KLGT expression does not require the addition of toxic compounds to the medium, which, at least in our hands, generally causes significant reduction of transformation efficiency. Moreover, with the use of KLGT we did not observe the appearance of revertants, which frequently appear with the other negative selection markers (unpublished observations). For these reasons, the development of an alternative and more simple counter-selection assay for efficient homologous recombination is of interest and utility.
The KLGT sequence was cloned using standard oligonucleotide cloning techniques (1). Expression of the KLGT from the constitutive TEF promoter from Ashbya gossypii (11) was lethal to the yeast strain JPY9 (Matα leu2 ura3 trp1 his3 lys2 gal4∆) (12) at low and normal temperatures of 24° and 30°C, respectively (data not shown). Toxicity of KLGT was reduced at 37°C, thus allowing growth at this temperature. The CDR3 V L of a prototype scFv on plasmid pVKS1/25 was replaced using homologous recombination either in the presence or in the absence of the negative selection marker. In the first case, the CDR3 V L was removed using PstI and BamHI restriction enzymes, which cut 30 and 80 bp from the CDR3 V L , respectively (Figure 1, A  and B) . For production of the target vector including the negative selection marker, the KLGT cassette was integrated into the scFv sequence so as to replace the CDR3 V L from the PstI to the BamHI site ( Figure 1B , CDR3L∆::P::KLGT) and linearized with XhoI between the promoter and the KLGT sequence ( Figure  1B ). The donor DNA fragment CDR3 V L was produced by PCR using oligonucleotides (Invitrogen, Carlsbad, CA, USA) CDR3f_40 (5′-CAGTGGATCT-GGGACAGAAT-3′) and CDR3r_60 (5′-GAGTCTCAGGGACCCCCCAG-3′), thus starting 40 bp upstream of the PstI site and terminating 60 bp downstream of the BamHI site. The resulting product was digested with DpnI to remove parental plasmid DNA and purified over is removed using suitable restriction enzymes (vertical arrows above scFv). Yeast cells are cotransformed with the linearized target vector and with the donor PCR fragment, which spans the sequence removed in the target vector and which bears homologies to the adjacent regions at its ends (dotted boxes). Upon recombination, the donor fragment is integrated into the corresponding site of the target vector, thus allowing propagation in yeast and cell growth (arrow to the left). Background vectors or nonhomologous recombination products, which do not encode functional proteins, still enable transformed cells to grow (arrow to the right). (B) The CDR3 of the light chain is deleted between the indicated restriction sites (vertical arrows) and replaced with the KLGT cassette (CDR3L∆::P::KLGT). The novel target vector is linearized between the promoter and the γ-toxin sequence (XhoI). Upon recombination with the donor PCR fragment, the promoter-KLGT module is looped out, the donor fragment is integrated into the corresponding site of the target vector, and cells can grow at 24°C (arrow to the left). If recombination does not take place properly, the γ-toxin is expressed, and the cells die at 24°C (arrow to the right).
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a QIAquick ® Spin Column (Qiagen, Valencia, CA, USA).
For cotransformation of the yeast strain JPY9 with target and donor DNA, 100 ng of either target vector and a 40× molar excess of donor DNA were combined. For homologous recombination, an optimized transformation protocol (13) was used. As a negative control, 100 ng of each of the linearized target vectors without donor DNA were used. Following transformation, the cells were spread onto selective minimal medium containing the required nutritional supplements (3) and incubated at 24°C until transformants were clearly visible. Colonies were then counted, and the number of transformants per microgram DNA was calculated. A total of six transformation experiments were performed. Cotransformation of the donor DNA and the target vector without the negative selection marker (scFv cut + CDR3 V L ) resulted in approximately 620,000 clones, and transformation of the linearized vector only (scFv cut) yielded approximately 10,500 colonies considered as vector background. This compares to approximately 360,000 transformants for cotransformation of the donor DNA and the target vector including the KLGT (scFv::PTEF::KLGT, XhoI + CDR3 V L ). Vector background (scFv::PTEF:: KLGT, XhoI) accounted for approximately 1200 colonies.
The recombination efficiency was then calculated as the ratio of the number of transformants from linearized target vector plus donor DNA divided by the number of transformants from linearized target vector. The number of transformants was stimulated 59× when donor DNA was included in the reaction using the standard target vector and 302× when using the target vector expressing the KLGT negative selection marker. While the total number of transformants might vary from experiment to experiment, recombination efficiency was constant in all experiments. Thus, the presence of the K. lactis γ-toxin on the target vector significantly reduced the number of background clones, while, on average, it lowered transformation efficiency less than 2×. Sequence analysis of the clones formed upon cotransformation confirmed that more than 95% of the clones had undergone a correct recombination event.
Use of the negative selection marker did not affect fidelity of recombination.
The method described here for domain replacement or randomization using homologous recombination in yeast coupled to counter-selection for nonrecombining clones offers important advantages over existing systems designed for the same purpose. First, in contrast to library production using cloning or strict homologous recombination, the negative selection protocol keeps the background below 0.3%, which may be essential in certain applications. Second, homologous recombination libraries with a complexity of a few million independent clones can be produced and screened in one single step in yeast. For antibodies, screening in yeast can be performed if the CDR library has been constructed on particularly stable frameworks that can properly fold and function in the reducing intracellular environment (14) . Alternatively, antibodies expressed in yeast can be selected upon extracellular localization using either the yeast display technology (15) or the extracellular twohybrid interaction assay (16) . Libraries produced by homologous recombination can also be stored indefinitely as yeast glycerol stocks, which allow direct use in further screenings. Upon extraction, these libraries can also be used for experiments in other organisms.
